FDA Drug recall D-0608-2024
DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW MAGNESIUM / LOW CALCIUM 4.25% DEXTROSE and attached stay "safe Exchange Set, 2500mL (Approx.…
- FDA Drug
- Class II
- ongoing
- Published 2024-07-24
On 2024-07-24 the FDA classified a Class II recall of DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW MAGNESIUM / LOW CALCIUM 4.25% DEXTROSE and attached stay "safe Exchange Set, 2500mL (Approx.… by Fresenius Medical Care Holdings, citing this product is being recalled due to the tube weld failure presents itself as a slow leak and can be difficult to detect.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0608-2024 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2024-06-18 |
| Published | 2024-07-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Fresenius Medical Care Holdings |
| Distribution | US |
Product
DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW MAGNESIUM / LOW CALCIUM 4.25% DEXTROSE and attached stay "safe Exchange Set, 2500mL (Approx. 50 mL excess), Single Dose Container Sterile and Non-Pyrogenic, For Intraperitoneal Administration Only, Fresenius Medical Care NA Waltham, MA 02451, 1-800-323-5188 NDC 49230-212-94
Reason
This product is being recalled due to the tube weld failure presents itself as a slow leak and can be difficult to detect.
Identifiers
| ndc | 49230-206-92 |
|---|---|
| ndc | 49230-206-94 |
| ndc | 49230-206-95 |
| ndc | 49230-209-92 |
| ndc | 49230-209-94 |
| ndc | 49230-209-95 |
| ndc | 49230-212-92 |
| ndc | 49230-212-94 |
| ndc | 49230-212-95 |
| code_info | 24AU03024, exp. date 07/31/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0608-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.